Best Prostatectomy with Robotic Assist Doctors in Englewood, NJ

We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.

Dr. Michael Palese, MD is an Urology Specialist who practices in New York, NY. He is 54 years old and has been practicing for 28 years. Dr. Michael Palese, MD is affiliated with Mount Sinai Morningside, Mount Sinai Brooklyn and Mount Sinai Hospital.

I understand the emotional burden that diagnosis of cancer can have on the patient and family members. I always would treat my patients as I would treatment my own family and friends. I understand quality of life is superbly important and would personalize treatment for each patient through extensive discussions and effective communication.

Urologic oncology is a multidisciplinary field that incorporates innovative surgical technology, systemic treatments such as chemotherapy as well as a focused research effort. As a Professor of Urology and the Clinical Director of Urologic Oncology I continually interact with colleagues in areas of medical oncology, radiation oncology, pathology among others in order to provide the most comprehensive and innovative care for our patients with prostate, bladder, kidney and testicular cancer. Advances in robotic technology along with scientific progress in our precision medicine program have allowed us to direct therapy in unprecedented ways. As a leader in this area I look forward to continued advances in this exciting and challenging field.

Urologic oncology is a multidisciplinary field that incorporates innovative surgical technology, systemic treatments such as chemotherapy as well as a focused research effort. As a Professor of Urology and the Clinical Director of Urologic Oncology I continually interact with colleagues in areas of medical oncology, radiation oncology, pathology among others in order to provide the most comprehensive and innovative care for our patients with prostate, bladder, kidney and testicular cancer. Advances in robotic technology along with scientific progress in our precision medicine program have allowed us to direct therapy in unprecedented ways. As a leader in this area I look forward to continued advances in this exciting and challenging field.

My passion for becoming a surgeon stemmed from a desire to help, love of sports (requiring dedication, teamwork and the pursuit of excellence) and the satisfaction from delivering cures. I was recruited to Weill Cornell Medicine (WCM) in February 2015 after establishing high volume, internationally renowned programs at Brigham and Women's Hospital/Harvard Medical School and UCLA Medical Center where I served as Director of the Prostate Cancer and Robotic and Minimally Invasive Surgery Programs, respectively. The desire to deliver transcendent care and push research in the largest and most dynamic U.S. metropolis led me to join the mission at WCM to deliver compassionate, high quality, personalized care for urologic oncology conditions.

Dr. Ketan Badani, MD is an Urology Specialist who practices in New York, NY. He is 50 years old and has been practicing for 24 years. Dr. Ketan Badani, MD is affiliated with Mount Sinai Queens, Mount Sinai Morningside and Mount Sinai Hospital.

I understand the emotional burden that diagnosis of cancer can have on the patient and family members. I always would treat my patients as I would treatment my own family and friends. I understand quality of life is superbly important and would personalize treatment for each patient through extensive discussions and effective communication.

Prostate cancer is a disease with highly variable outcomes - many patients have slow growing cancers that will never threaten their health, while other have aggressive cancers that may rapidly progress. A variety of new tools are available to help urologists match the right patient with the right treatment course, from cutting edge tests exposing the molecular basis of these cancers to imaging techniques that can allow precise targeting of cancers. A urologist that understands the use and limitations of these tools is critical to get the best outcomes. I am both a prostate cancer surgeon and a highly active researcher in prostate cancer genomics in the Sandra and Edward Meyer Cancer Center at Weill Cornell, allowing me to stay at the forefront of prostate cancer care in the 21st century, and delivering the best possible care to patients at Weill Cornell.